Search results
-
Ricoh Company, Ltd.
Eccles, Robert G.; Edmondson, Amy C.; Iansiti, Marco; Kanno, AkikoCase HBS-610053-EService and Operations ManagementRicoh, the Japanese copier manufacturer, is committed to reducing its environmental impact to one-eighth of its 2000 levels by 2050. It has already introduced three stages of environmental awareness to its operations, and its recycled copier business broke even in 2006. The company developed environmental accounting methods and produces annual environmental and sustainability reports, but Ricoh is concerned that investors may not take these effor...Starting at €8.20
-
InterfaceRAISE: Sustainability Consulting, Teaching Note
Toffel, Michael W.; Eccles, Robert G.Teaching Note HBS-612049-EService and Operations ManagementTeaching Note for 611-069.Starting at €0.00
-
New Balance Athletic Shoe, Inc. (Abridged)
Bowen, H. Kent; Huckman, Robert S.; Knoop, Carin-Isabel; Preble, MatthewCase HBS-613006-EService and Operations ManagementConsiders whether New Balance, one of the world's five largest manufacturers of athletic footwear, should respond to Adidas' planned acquisition of Reebok-a transaction that would join the second- and third-largest companies in the industry. Highlights the unique aspects of New Balance's strategy-focusing on fit and performance by offering long-lived shoes in a wide variety of widths and eschewing celebrity endorsement of its products-and discuss...Starting at €8.20
-
Weber Shandwick: The Client Relationship Leader Program
Eccles, Robert G.; Herman, KerryCase HBS-408077-EService and Operations ManagementIn 2002 Weber Shandwick, a leading global public relations agency, instituted a Client Relationship Leader (CRL) Program for its top 32 global accounts. The purpose of the program is to ensure that all of the firm's resources across geographies, practice areas, and specialty areas are coordinated and effectively delivered to Weber Shandwick's most important clients. Each of these clients is assigned a "Client Relationship Leader" and the case dis...Starting at €8.20
-
Sustainability: Bringing Life to Your Business
Barcelona, Ricardo; Berrone, Pascual; Eccles, Robert G.; Van Wassenhove, Luk N.Dossier DOS-8-EAccounting and Control, Corporate Governance, Marketing, Service and Operations ManagementA new era is dawning in which social, environmental and economic value creation is bubbling up on the horizon.Starting at €15.00
-
The Performance Frontier: Innovating for a Sustainable Strategy
Eccles, Robert G.; Serafeim, GeorgeArticle HBS-R1305B-EService and Operations ManagementToo often, companies launch sustainability programs with the hope that they'll be financially rewarded for doing good, even when those programs aren't relevant to their strategy and operations. They fail to understand the trade-offs between financial performance and performance on environmental, social, and governance (ESG) issues. Improving one typically comes at a cost to the other. But it doesn't have to be this way. It's possible to simultane...Starting at €8.20
-
Weber Shandwick: The Client Relationship Leader Program, Teaching Note
Eccles, Robert G.; Rossano, PenelopeTeaching Note HBS-412023-EService and Operations ManagementTeaching Note for 408077.Starting at €0.00
-
First Boston's Union Carbide Deal: Acquiring a New Client, Teaching Note
Eccles, Robert G.; Rossano, PenelopeTeaching Note HBS-411090-EService and Operations ManagementTeaching Note for 897201.Starting at €0.00
-
Sostenibilidad: larga vida a su negocio
Barcelona, Ricardo; Berrone, Pascual; Eccles, Robert G.; Van Wassenhove, Luk N.Dossier DOS-8Accounting and Control, Corporate Governance, Marketing, Service and Operations ManagementSe habla mucho de empresas sostenibles. Pero, ¿cómo integrar a la sociedad y el entorno en la cuenta de resultados?Starting at €15.00
-
MorphoSys AG: The Evolution of a Biotechnology Business Model
Pisano, Gary P.; Johnson, Ryan; Knoop, Carin-IsabelCase HBS-611046-EService and Operations ManagementIn the biotech world, the 18-year-old Munich-based company MorphoSys was a rarity: it was profitable. The company achieved this profitability not by developing and selling its own drugs, but by licensing access to its proprietary library of human antibodies. Recently, the company decided to deviate from this model, and attempt to develop its own proprietary products. The case allows analysis of "license vs. vertically integrate" business model de...Starting at €8.20